FRACTYL HEALTH, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $0 | $93,000 | $120,000 | — |
| Cost of revenue | $0 | $50,000 | $77,000 | — |
| Gross profit | — | $43,000 | $43,000 | — |
| Selling, general & administrative | $22.3M | $23.1M | $12.8M | — |
| Research and development | $74.5M | $70.5M | $38.0M | — |
| Operating expenses | $96.8M | $93.6M | $50.9M | — |
| Operating income | -$96.8M | -$93.5M | -$50.8M | — |
| Income tax expense | $0 | $0 | $0 | — |
| Net income | -$141.0M | -$68.7M | -$77.1M | — |
| Balance Sheet | ||||
| Cash and equivalents | $81.5M | $67.5M | $33.2M | — |
| Current assets | $87.6M | $71.8M | $35.6M | — |
| Total assets | $121.4M | $108.1M | $76.2M | — |
| Current liabilities | $18.3M | $19.8M | $11.2M | — |
| Total liabilities | $111.9M | $79.7M | $113.9M | — |
| Stockholders' equity | $9.5M | $28.4M | -$325.1M | -$252.3M |
| Cash Flow Statement | ||||
| Cash from operations | -$90.3M | -$65.5M | -$42.8M | — |
| Depreciation and amortization | $1.1M | $677,000 | $286,000 | — |
| Stock-based compensation | $6.7M | $14.4M | $4.3M | — |
| Capital expenditure | $557,000 | $1.8M | $359,000 | — |
| Free cash flow | -$90.9M | -$67.3M | -$43.2M | — |
Shares outstanding 158.6M · Free float 74.8%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.